Your current location is:{Current column} >>Text
Eli Lilly shares tumble as Q3 misses estimates, guidance lowered By
{Current column}55People have watched
Introduction-- Eli Lilly (NYSE:) shares plunged around 10% in premarket trading on Wednesday after it reported t ...
-- Eli Lilly (NYSE:) shares plunged around 10% in premarket trading on Huanma Forex official websiteWednesday after it reported third-quarter earnings that fell short of analyst expectations.
The pharmaceutical giant posted adjusted earnings per share of $1.18, missing the consensus estimate of $1.45. Revenue came in at $11.44 billion, below analyst projections of $12.09 billion.
Despite falling short of expectations, revenue grew 20% YoY, boosted by strong sales of diabetes drug Mounjaro and weight loss treatment Zepbound. Excluding those products, non-incretin revenue increased 17%.
The company lowered its full-year 2024 revenue guidance to between $45.4 billion and $46 billion, down from its previous forecast of $45.4 billion to $46.6 billion and below the $46.25 billion analysts were expecting.
Eli Lilly also cut its 2024 adjusted EPS outlook to between $13.02 and $13.52, compared to the $13.50 consensus estimate. The previous EPS forecast was from $16.10 to $16.60.
"Lilly had another strong growth quarter in Q3, with total revenue increasing by 42% after excluding divestiture activity in the same period last year," said CEO David Ricks. "While the growth of Mounjaro and Zepbound is impressive, we are equally proud of the 17% growth in non-incretin revenue."
Prior to the premarket decline on Wednesday, Eli Lilly shares had gained over 55% for the year-to-date.
Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!Tags:
Related articles
U.S. weekly jobless claims jump to highest level since late 2021 By Reuters
{Current column}WASHINGTON (Reuters) - The number of Americans filing new claims for jobless benefits jumped last we ...
Read moreOpening Bell: Futures Slip As Traders Digest Solid Economic Data Vs. Hawkish Fed
{Current column}Powell promises continuous hikes till evidence of cooling inflationUS retail sales increase, manufac ...
Read moreUkraine and Russia: What you need to know right now By Reuters
{Current column}2/2© Reuters. Ukrainian national flag is seen through the window of an apartment destroyed during Ru ...
Read more
Popular Articles
- Gold rises amid bets on Fed pause in June, debt ceiling in focus By
- Gold’s Trading Range Could Widen To $70 As U.S. Dollar Not Backing Down
- Weekly Outlook: RBA Minutes; UK Employment, CPIs And Retail Sales
- Asian shares tumble as global growth fears mount By Reuters
- Trump's lawyer calls civil rape case an affront to justice system By Reuters
- Marketmind: Extreme fear? Seriously? By Reuters
Latest articles
-
Stock market today: Dow closes lower as energy, Home Depot slip By
-
Siemens Energy launches $4.3 billion bid for remaining Siemens Gamesa stake By Reuters
-
Aging Badly
-
The Politics Of Sound Money: What’s At Stake
-
European stock futures edge higher; German inflation data in focus By
-
Dow Futures Up 280 Pts; Chinese Cut, Palo Alto Earnings in Focus By